abrdn plc Makes New Investment in Integral Ad Science Holding Corp. (NASDAQ:IAS)

abrdn plc purchased a new position in Integral Ad Science Holding Corp. (NASDAQ:IAS) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 1,757,114 shares of the company’s stock, valued at approximately $25,285,000. abrdn plc owned 1.11% of Integral Ad Science at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Skandinaviska Enskilda Banken AB publ bought a new position in Integral Ad Science in the third quarter worth approximately $58,000. DekaBank Deutsche Girozentrale bought a new stake in shares of Integral Ad Science during the 3rd quarter valued at $62,000. Amalgamated Bank raised its position in shares of Integral Ad Science by 19.9% during the 3rd quarter. Amalgamated Bank now owns 6,951 shares of the company’s stock valued at $83,000 after purchasing an additional 1,156 shares during the period. Sherbrooke Park Advisers LLC bought a new stake in shares of Integral Ad Science during the 3rd quarter valued at $140,000. Finally, L2 Asset Management LLC bought a new stake in shares of Integral Ad Science during the 3rd quarter valued at $142,000. 95.78% of the stock is currently owned by institutional investors.

Integral Ad Science Stock Performance

Shares of NASDAQ:IAS opened at $9.57 on Wednesday. Integral Ad Science Holding Corp. has a 52 week low of $8.92 and a 52 week high of $20.88. The stock has a market capitalization of $1.53 billion, a P/E ratio of 239.31, a PEG ratio of 1.59 and a beta of 1.60. The firm has a fifty day simple moving average of $11.02 and a two-hundred day simple moving average of $13.00. The company has a quick ratio of 3.21, a current ratio of 3.21 and a debt-to-equity ratio of 0.17.

Integral Ad Science (NASDAQ:IAS) last issued its quarterly earnings data on Tuesday, February 27th. The company reported $0.06 EPS for the quarter, topping analysts’ consensus estimates of $0.03 by $0.03. Integral Ad Science had a net margin of 1.53% and a return on equity of 0.83%. The business had revenue of $134.30 million during the quarter, compared to analysts’ expectations of $131.27 million. During the same period last year, the company posted $0.07 EPS. The business’s revenue was up 14.4% on a year-over-year basis. On average, analysts expect that Integral Ad Science Holding Corp. will post 0.16 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the stock. Barclays decreased their price objective on shares of Integral Ad Science from $16.00 to $12.00 and set an “equal weight” rating on the stock in a research report on Monday, April 15th. Bank of America assumed coverage on shares of Integral Ad Science in a research report on Thursday, January 11th. They set a “buy” rating and a $19.00 price objective on the stock. Oppenheimer reduced their price target on shares of Integral Ad Science from $25.00 to $20.00 and set an “outperform” rating on the stock in a report on Wednesday, February 28th. Morgan Stanley reiterated an “equal weight” rating and issued a $12.00 price target (down from $18.00) on shares of Integral Ad Science in a report on Tuesday, April 16th. Finally, Truist Financial reduced their price target on shares of Integral Ad Science from $26.00 to $17.00 and set a “buy” rating on the stock in a report on Wednesday, February 28th. Three investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $17.58.

Insider Activity at Integral Ad Science

In related news, CEO Lisa Utzschneider sold 13,113 shares of the company’s stock in a transaction dated Tuesday, February 6th. The shares were sold at an average price of $15.79, for a total transaction of $207,054.27. Following the transaction, the chief executive officer now directly owns 148,657 shares in the company, valued at approximately $2,347,294.03. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Integral Ad Science news, CFO Tania Secor sold 6,570 shares of the company’s stock in a transaction dated Wednesday, March 6th. The shares were sold at an average price of $9.71, for a total value of $63,794.70. Following the transaction, the chief financial officer now directly owns 230,888 shares in the company, valued at approximately $2,241,922.48. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Lisa Utzschneider sold 13,113 shares of the company’s stock in a transaction dated Tuesday, February 6th. The stock was sold at an average price of $15.79, for a total transaction of $207,054.27. Following the completion of the transaction, the chief executive officer now owns 148,657 shares in the company, valued at $2,347,294.03. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 80,195 shares of company stock worth $876,562. Insiders own 2.00% of the company’s stock.

Integral Ad Science Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.